Revolution Medicines stock surges over 20% on potential AbbVie acquisition

Go back to Revolution Medicines stock surges over 20% on potential AbbVie acquisition
AbbVie (NYSE: ABBV) Delayed: 264.96 +3.13 (1.20%)
Previous Close $261.83    52 Week High $68.12 
Open $260.70    52 Week Low $50.71 
Day High $266.84    P/E 57.48 
Day Low $260.10    EPS $4.61 
Volume 5,157,114       

(NASDAQ: ERAS) Delayed: 17.63 +0.55 (3.22%)
Previous Close $17.08    52 Week High
Open $17.28    52 Week Low
Day High $17.84    P/E N/A 
Day Low $17.21    EPS
Volume 2,445,434       

(NASDAQ: RVMD) Delayed: 209.46 -2.28 (1.08%)
Previous Close $211.74    52 Week High
Open $212.06    52 Week Low
Day High $212.74    P/E N/A 
Day Low $206.75    EPS
Volume 2,124,090       

(NASDAQ: TNGX) Delayed: 23.88 +0.37 (1.57%)
Previous Close $23.51    52 Week High
Open $23.95    52 Week Low
Day High $24.36    P/E N/A 
Day Low $23.48    EPS
Volume 2,489,382       

VERASTEM SHS (NASDAQ: VSTM) Delayed: 6.89 +0.07 (1.03%)
Previous Close $6.82    52 Week High $2.43 
Open $6.88    52 Week Low $1.05 
Day High $7.02    P/E N/A 
Day Low $6.78    EPS $-1.79 
Volume 996,115